Laurion Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Laurion Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-771,913	Closed	-$48M	–	660
2023 Q4	$48M	Sell	771,913 -200,000	-21%	-$4.97M	0.41%	66
2023 Q3	$21.6M	Buy	+971,913	New	+$20.4M	0.13%	140

Laurion Capital Management's RYZB Position: Q1 2024 in Review

Laurion Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 771,913 shares — an estimated $48M sold.

Laurion Capital Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $48M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Laurion Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Laurion Capital Management sold 771,913 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $48M.
Laurion Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Laurion Capital Management's RayzeBio, Inc. Common Stock position peaked at $48M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Laurion Capital Management's 13F filing for Q1 2024, filed 15 May 2024.